• Medical tourism insulation: The company's reliance on medical tourism is minimal as revenue is driven almost entirely by local micro-markets, insulating operations from geopolitical tensions in the Middle East despite global supply chain cost pressures.
• Hospital margin outlook: Operating margins at mature facilities in Thane and Pune remain protected, Indore continues to see growth, and the newly launched Dombivli hospital is expected to drag on EBITDA for two years before breaking even.
• Capacity expansion pipeline: Expansion plans to scale total bed capacity from 1,248 to 2,900 beds remain on track, led by a 500-bed hospital in South Pune targeted for a 2028 launch, followed by projects in Mira Road and a 400-bed hospital in BKC.
• Occupancy metric trends: Asset peak occupancy is targeted at 70% to 75% over a 6 to 7-year ramp-up; the reported occupancy decline from 65.3% to 61.2% reflects denominator dilution from adding 100 beds in Indore rather than a drop in absolute occupied bed days.
• Funding and capex: Phased over 4 to 4.5 years, greenfield expansion will be financed entirely through internal cash flows, supported by ₹550 crore in cash reserves and annual EBITDA of around ₹350 crore.